Avoiding inappropriate ventricular tachycardia detection due to T-wave oversensing in an implantable cardioverter defibrillator: A novel application of the electrogram width criterion

Europace

Volumn 3, Issue 1, 2001, Pages 80-84

  Duru, Firat ^a   Bauersfeld, U ^a   Candinas, R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Detection enhancement; Electrogram width criterion; Implantable cardioverter defibrillator; T wave oversensing; Ventricular tachycardia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; METOPROLOL;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PROTOCOL; DEFIBRILLATION; DEFIBRILLATOR; ELECTROGRAPHY; HEART RATE; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; MALE; PRIORITY JOURNAL; REFRACTORY PERIOD; SIGNAL DETECTION; T WAVE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0035113587     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1053/eupc.2000.0145     Document Type: Article

References (22)

1. Oversensing by single-chamber pacemakers: Mechanisms, diagnosis, and treatment
2. The automatic implantable cardioverter defibrillator: T wave sensing in the newest generation
3. Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators
4. Complications of implantable cardioverter defibrillator therapy: Follow-up of 241 patients
5. Implantable cardioverter-defibrillator therapy in the absence of significant symptoms. Rhythm diagnosis and management aided by stored electrogram analysis
6. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator
7. Sensing and tachyarrhythmia detection problems in implantable cardioverter defibrillators
8. Myopotential sensing by a dual chamber implantable cardioverter defibrillator: Two case reports
9. Clinical interactions between pacemakers and automatic implantable cardioverter-defibrillators
10. Kombinierte Therapie mit transvenosen Kardioverter/Defibrillator- und antibradykarden Schrittmachersystemen
11. Interactions between transvenous nonthoracotomy cardioverter defibrillator systems and permanent transvenous endocardial pacemakers
12. Inhibition of bradycardia pacing caused by far-field atrial sensing in a third-generation cardioverter defibrillator with an automatic gain feature
13. Transient early T wave sensing by implanted programmable demand pulse generator
14. Problems in managing patients with long QT syndrome and implantable cardioverter defibrillators: A report of two cases
15. Pseudo-oversensing of the T wave by an implantable cardioverter defibrillator: A nonclinical problem
16. Comparison of oversensing during bradycardia pacing in two types of implantable cardioverter-defibrillator systems
17. Intracardiac QRS electrogram width - An arrhythmia detection feature for implantable cardioverter defibrillators: Exercise induced variation as a base for device programming
18. The potential for inappropriate ventricular tachycardia confirmation using the intracardiac electrogram width criterion
19. The need for exercise testing for optimal programming of the EGM width criterion in patients with an implantable defibrillator
20. Effect of slew threshold on electrogram width during ventricular tachycardia: Recommendations for optimal function of the EGM width criterion in an implantable cardioverter-defibrillator